Stimulation of P‐glycoprotein‐mediated drug transport by prazosin and progesterone
- 1 February 1999
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 259 (3) , 841-850
- https://doi.org/10.1046/j.1432-1327.1999.00098.x
Abstract
P-glycoprotein is a plasma membrane protein of mammalian cells that confers multidrug resistance by acting as a broad-specificity, ATP-dependent efflux transporter of diverse lipophilic neutral or cationic compounds. Previously, we identified two positively cooperative drug-binding sites of P-glycoprotein involved in transport [Shapiro, A.B. & Ling, V. (1997) Eur. J. Biochem.250, 130–137]. The H site is selective for Hoechst 33342 and colchicine. The R site is selective for rhodamine 123 and anthracyclines. Substrate binding to one site stimulates transport by the other. In this paper, we show that prazosin and progesterone stimulate the transport of both Hoechst 33342 and rhodamine 123. Rhodamine 123 and prazosin (or progesterone) in combination stimulate Hoechst 33342 transport in an additive manner. In contrast, Hoechst 33342 and either prazosin or progesterone interfere with each other, so that the stimulatory effect of the combination on rhodamine 123 transport is less than that of each individually. Non-P-glycoprotein-specific effects of prazosin on membrane fluidity and permeability were excluded. These results indicate the existence of a third drug-binding site on P-glycoprotein with a positive allosteric effect on drug transport by the H and R sites. This allosteric site appears to be one of the sites of photoaffinity labeling of P-glycoprotein by [125I]iodoarylazidoprazosin [Safa, A.R., Agresti, M., Bryk, D. & Tamai, I. (1994) Biochemistry33, 256–265] and is likely not to be capable of drug transport.Keywords
This publication has 29 references indexed in Scilit:
- Transport of LDS‐751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine‐123‐selective site of P‐glycoproteinEuropean Journal of Biochemistry, 1998
- Positively Cooperative Sites for Drug Transport by P‐Glycoprotein with Distinct Drug SpecificitiesEuropean Journal of Biochemistry, 1997
- P‐Glycoprotein‐Mediated Hoechst 33342 Transport Out of the Lipid BilayerEuropean Journal of Biochemistry, 1997
- The multi‐drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P‐glycoprotein by an allosteric interactionBritish Journal of Pharmacology, 1997
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.Journal of Clinical Investigation, 1996
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- Potentiation of Anticancer-Drug Cytotoxicity by Multidrug-Resistance Chemosensitizers Involves Alterationsin Membrane Fluidity Leading to Increased Membrane PermeabilityEuropean Journal of Biochemistry, 1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical propertiesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992